Navigation Links
Medivation's Dimebon(TM) Significantly Improved Daily Function in Alzheimer's Disease Patients, Resulting in Reduced Need for Caregiver Assistance
Date:4/15/2008

- Activities of Daily Living Data from Pivotal Trial Presented at American

Academy of Neurology 60th Annual Meeting -

SAN FRANCISCO and CHICAGO, April 15 /PRNewswire-FirstCall/ -- Medivation, Inc. (Nasdaq: MDVN) today announced that Alzheimer's patients taking the investigational drug Dimebon(TM) showed significant improvement in their ability to perform daily tasks over a one-year period compared to placebo. This improvement allowed caregivers to save an average of nearly one hour (51 minutes) each day caring for patients. The benefits of Dimebon were seen in eating, toilet use, phone use, conversation, meal preparation, traveling, keeping appointments, reading and using household appliances. These clinical results were generated during a pivotal trial of Dimebon in patients with mild-to-moderate Alzheimer's disease (AD).

The data were presented today during a poster session on "Aging and Dementia: Treatment" at the 60th Annual Meeting of the American Academy of Neurology (AAN) by Rachelle Doody, M.D., Ph.D., the Effie Marie Cain Chair in Alzheimer's Disease Research at the Alzheimer's Disease and Memory Disorders Center, Baylor College of Medicine in Houston.

"After one year of therapy with Dimebon, Alzheimer's disease patients performed better in daily function than patients who did not get Dimebon, allowing them to maintain their functionality and decreasing the time needed by caregivers to assist with daily activities," said Dr. Doody. "In contrast, placebo-treated patients declined in function and required greater caregiver assistance, as would be expected given the natural progression of this neurological disease."

Dimebon Significantly Improved Activities of Daily Living at Both Six Mont
'/>"/>

SOURCE Medivation, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Medivations Dimebon(TM) Stabilizes Behavioral Symptoms in Alzheimers Disease Patients, Resulting in Reduced Caregiver Distress
2. Orqis(R) Medicals Cancion(R) System Significantly Increases Cardiac Performance
3. CV Therapeutics Anti-Ischemic Therapy Ranexa(R) Significantly Reduces Cardiac Chest Pain Symptoms and Recurrent Ischemia in MERLIN-TIMI 36 Patients With Angina
4. Perioperative Eloxatin(R)-Based Regimen Significantly Reduced the Risk of Relapse Versus Surgery Alone in Eligible Colorectal Cancer Patients with Initially Resectable Liver Metastases
5. Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs
6. Everolimus (RAD001) Significantly Extends Progression-Free Survival in Advanced Kidney Cancer Patients After Failure of Other Targeted Therapy
7. Phase I and Phase I/II DCVax(R)-Brain Data Continues to Show Significantly Improved Survival Rates for Brain Cancer Patients
8. New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies
9. TREANDA Significantly Improves Clinical Outcomes in Patients with Chronic Lymphocytic Leukemia Compared to Chlorambucil
10. Access Pharmaceuticals Demonstrates Ability to Significantly Reduce Glucose Levels in Pre-clinical Testing of Cobalamin(TM) Oral Insulin
11. Phase 3 Data Show New Anti-TNF, Golimumab, Significantly Improved Arthritis, Skin and Nail Manifestations in Patients with Psoriatic Arthritis

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)... ,, NEWYORK,Nov.23/PRNewswire/--Reportlinker...leinitscatalogue. ,, SterilizationSystems&.../www.reportlinker.com/p0164340/Sterilization-Syste...tm_source=prnewswire&utm_medium=pr&utm_cam...nuestobethemostimportantandwidelyusedprocedure.Ste...
(Date:11/23/2009)... ,, MINNEAPOLIS,Nov.23/PRNewswire/--BridgePo...rk(ConformiteEuropeene)foritscoronaryandperipheral...ftheCrossBoss(TM)CTOCrossingCatheterandtheStingray...iesofinterventionalcathetersthataredesignedtonavig...restorationviaangioplastyandstenting. ,, TheNat...
(Date:11/23/2009)... ,, THEWOODLANDS,Texas,Nov.23/PRNewswire-Fir...X ),announcedtodaythattop-linedatafromitsPhase2cli...ngirritablebowelsyndrome(IBS)willbepresentedatGAST...owedasignificantimprovementinIBSsymptoms,willbepre...identofclinicaldevelopment,onNovember25,2009at2:30...
Breaking Medicine Technology:Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 2Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 3Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 4Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 5Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 6Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 7BridgePoint Medical(R) Receives European CE Mark for Stingray(R) and CrossBoss(TM) for Opening Completely Blocked Arteries 2Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 2Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 3Body Clock Blood Sugar Control Seem Linked 59234 1Body Clock Blood Sugar Control Seem Linked 59234 2KEAP1 Keeps major cancer promoting protein at bay 59230 1KEAP1 Keeps major cancer promoting protein at bay 59230 2Face Masks for Patients May Leak Spread Germs 59226 1Face Masks for Patients May Leak Spread Germs 59226 2
...ly Detection of Alzheimer,s and Parkinson,s Diseas...mic, Inc. (OTC Bulletin Board: TBIO) and Power3 Me...day announced they have finalized a transaction, p... December 2, 2008 (see "Transgenomic Signs Letter ...th Option to Acquire Power3 Medical Products, Neur...
... Men who experience erectile dysfunction between t...p heart disease than men without dysfunction, acco...s also found that men with erectile dysfunction ha... , "The highest risk for coronary heart disease wa...uver, Ph.D. The study was published in the Februar...
Other Medicine Technology:Transgenomic and Power3 Medical Complete Agreement for Exclusive License of Neurodegenerative Biomarker Test 2Transgenomic and Power3 Medical Complete Agreement for Exclusive License of Neurodegenerative Biomarker Test 3Transgenomic and Power3 Medical Complete Agreement for Exclusive License of Neurodegenerative Biomarker Test 4Mayo Clinic Study Finds Younger Men With Erectile Dysfunction at Double Risk of Heart Disease 2Mayo Clinic Study Finds Younger Men With Erectile Dysfunction at Double Risk of Heart Disease 3
(Date:11/23/2009)...tedConcordiaDental,oneofthenation,slargestdentalin...unitedconcordia.comwhichprovidesimprovedaccesstoin.... ,, "Thesiteboastsacleandesign,betterorganizat...itorsfindinformationquicklyandeasily,"saidPaulJone...."Fresh,relevantcontent,coupledwithanimprovedeaseo...
(Date:11/23/2009)...ade,M.D.announcesthenewlyenhancedCyberKnifeequipme...fMiami,( www.cyberknifemiami.com ). ,, TheCyb...sedoseofradiationthatkillscancercellswithnoinvasiv...om30minutestoonehour,andisusuallycompletedin1-5tre...intheSoutheasternU.S.,theMiamifacilityhasledtheway...
(Date:11/23/2009)...al and physical health , , MONDAY, Nov. ...as many years off your life as smoking does, a new...pression and anxiety appears to be better for long...to their conclusions after analyzing death records...he four years after the survey, the death rate was...
(Date:11/23/2009)...ovember issue of GIE: Gastrointestinal Endoscopy ...the American Society for Gastrointestinal Endoscop... that Barrett,s esophagus was detected in six perc...reening. Also in this issue, two studies examined ...ce, in the largest single-center experience to dat...
(Date:11/23/2009)...ystem study has found that one out of five Type 2 ...ounds or more overweight. , Researchers reported...etes are obese, and 20.7 percent are morbidly obes...tes, 1 in 3 is morbidly obese. , "The rate of mo...ing at a very alarming rate, and this has substant...
Breaking Medicine News(10 mins):Health News:Depression May Up Death Risk to That of Smoking 2Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 2Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 3Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 4Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 5Health News:Diabetics show alarming increase in morbid obesity 2
...d of protection against bird flu has been studied ...at the University of Rochester. // This involves a...emic of bird flu hits, it would take months to dev...accination. An initial dose of the vaccine is give...
...st advanced nations of the world today, Britain ha...e most 'obese nation in Europe' last week. //In a ... more than one –fourth of the nation's population ...ards improving people's quality of life through go...
...rds today throughout the country are 'Dengue' an...brought on by the bite of an infected// Aedes aeg...olling in several Indian states. Dengue is the m...ning to go out of hand unless a formidable solutio...
...eople have died of dengue fever in the Dominican R... the health authorities announced a drop in the nu...al patients hit by the disease this year is nearly...ojas said a large number of student volunteers wil...
...avels that other factors play a strong role along ...Down's Syndrome.// Many older women who have been ...ound out that they are pregnant often find themsel...us (unborn developing baby) being malformed or men...
...rs at the Launceston General Hospital have develop... According to the director of the LGH Dementia Res...luid from the brain can treat one type of dementia... and women of the age 58-92 years, from the hospit...
Other Medicine News:Health News:Dengue and Chikungunya: The Dirge of a Nation 2Health News:Dengue and Chikungunya: The Dirge of a Nation 3Health News:Dengue and Chikungunya: The Dirge of a Nation 4Health News:Cause of ‘Down Syndrome’ cannot be pinned down to maternal age alo 2
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
Medicine Products: